Inhibition or Treatment of Dyskinesia
View/ Open
Author
School of Life and Medical Sciences
Centre for Research in Mechanisms of Disease and Drug Discovery
Department of Clinical, Pharmaceutical and Biological Science
Basic and Clinical Science Unit
Centre for Health Services and Clinical Research
Iravani, Mahmoud M.
Jenner, Peter
Attention
2299/15693
Abstract
Prevention or treatment of dyskinesia induced by L-dopa or dopamine agonist can be effected by use of a selective inhibitor of neuronal nitric oxide synthase